Literature DB >> 10543349

HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt.

M Divizia1, R Gabrieli, M L Stefanoni, E Renganathan, E El Ghazzawi, O A Kader, F Gamil, G El Sawaf, E El Sherbini, E Saleh, A M Degener, A Noce, L Zaratti, A Modesti, A Panà.   

Abstract

A total of 202 serum and stool samples from acute hepatitis patients attending the Fever Hospital of Alexandria, Egypt, have been studied to reveal markers of hepatitis virus infection. Anti-HAV IgM were detected in 21 out of 202 sera (10.4%), whereas 201 sera (99.5%) had anti-HAV IgG. The first age attack was in the class-age 0-9 years with 64.7% of anti-HAV IgM positive sera. Among 202 patients, anti-hepatitis E IgG (sample/over cut off > 1.0) was identified in 90 patients (44.5%). The anti-HEV seropositivity ranged from 17.6% to 60.0% in the different age groups, with the highest level in the class-age 20 29 years. Anti-hepatitis E IgM were identified in 49 patients with the first age attack in the class-age 10-19 years (39.4%). HAV RNA was identified by nested PCR in 7 samples out of 15, whereas HEV RNA was present in 4 out of 75 stool samples. Direct DNA sequence of the latter PCR products confirmed the presence of the HEV genome; comparison of the sequences of the isolates from Egypt with those in data banks revealed the highest homology to the Burma strain. Our data confirm that HAV and HEV are common causes of acute sporadic hepatitis in Alexandria but with different peak age positivity. Occasionally, but not infrequently, dual infections (HAV-HEV and HEV-enteric viruses) were also found. The risk analysis indicates that patients living in rural areas are exposed to a higher risk of hepatitis E infection compared to the urban population, whereas the presence of anti-HEV IgG was significantly associated with consumption of common village water and use of indoor dry pit and oral therapy for schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543349     DOI: 10.1023/a:1007514030062

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  26 in total

1.  Acute sporadic hepatitis in adults living in Cairo, Egypt.

Authors:  S Bassily; K C Hyams; N M el Ghorab; A A Ansari; A S Fanous
Journal:  Am J Trop Med Hyg       Date:  1986-09       Impact factor: 2.345

2.  Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987.

Authors:  O Velázquez; H C Stetler; C Avila; G Ornelas; C Alvarez; S C Hadler; D W Bradley; J Sepúlveda
Journal:  JAMA       Date:  1990-06-27       Impact factor: 56.272

3.  Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method.

Authors:  R W Jansen; G Siegl; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua.

Authors:  O M Perez; W Morales; M Paniagua; O Strannegard
Journal:  Am J Trop Med Hyg       Date:  1996-07       Impact factor: 2.345

5.  Hepatitis A virus identification in an outbreak by enzymatic amplification.

Authors:  M Divizia; C Gnesivo; R Amore Bonapasta; G Morace; G Pisani; A Panà
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

6.  Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction.

Authors:  N Jothikumar; K Aparna; S Kamatchiammal; R Paulmurugan; S Saravanadevi; P Khanna
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

7.  Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

Authors:  R Goldsmith; P O Yarbough; G R Reyes; K E Fry; K A Gabor; M Kamel; S Zakaria; S Amer; Y Gaffar
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

8.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  The etiology of acute hepatitis in hospitalized children in Cairo Egypt.

Authors:  S Zakaria; R S Goldsmith; M S Zakaria; M A Kamel; E H el-Raziky
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

10.  Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India.

Authors:  V A Arankalle; J Jha; M O Favorov; A Chaudhari; H A Fields; K Banerjee
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

View more
  9 in total

1.  Application of a molecular panel to demonstrate enterotropic virus shedding by healthy and human immunodeficiency virus-infected patients.

Authors:  Claudia Minosse; Maria S Zaniratti; Silvia Calcaterra; Fabrizio Carletti; Michele Muscillo; Marina Pisciotta; Letizia Pillitteri; Angela Corpolongo; Francesco Nicola Lauria; Pasquale Narciso; Gianfranco Anzidei; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 2.  Involvement of Egyptian Foods in Foodborne Viral Illnesses: The Burden on Public Health and Related Environmental Risk Factors: An Overview.

Authors:  Hamada Aboubakr; Sagar Goyal
Journal:  Food Environ Virol       Date:  2019-09-27       Impact factor: 2.778

3.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

4.  Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.

Authors:  Jason T Blackard; Susan D Rouster; Soad Nady; Gehan Galal; Naglaa Marzuuk; Marwaa M Rafaat; Enas Daef; Salwa Seif El Din; Robert H Purcell; Suzanne U Emerson; Kenneth E Sherman; M Tarek Shata
Journal:  J Clin Virol       Date:  2009-08-03       Impact factor: 3.168

5.  Viral hepatitis a to e in South mediterranean countries.

Authors:  Sanaa M Kamal; Sara Mahmoud; Tamer Hafez; Runia El-Fouly
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-02-10       Impact factor: 2.576

Review 6.  A systematic review of the epidemiology of hepatitis E virus in Africa.

Authors:  Jong-Hoon Kim; Kenrad E Nelson; Ursula Panzner; Yogita Kasture; Alain B Labrique; Thomas F Wierzba
Journal:  BMC Infect Dis       Date:  2014-06-05       Impact factor: 3.090

7.  Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt.

Authors:  Ibrahim M Sayed; Mohamed A El-Mokhtar; Mahmoud Abdel Rahman Mahmoud; Amal A Elkhawaga; Shereen Gaber; Nermien H Seddek; Lobna Abdel-Wahid; Ahmed M Ashmawy; Enas Ahmed Reda Alkareemy
Journal:  Infect Drug Resist       Date:  2021-01-12       Impact factor: 4.003

Review 8.  Advances in Hepatitis E Virus Biology and Pathogenesis.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

9.  Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil.

Authors:  Ana Maria Passos-Castilho; Anne de Sena; Ana Lucia Coutinho Domingues; Edmundo Pessoa Lopes-Neto; Tibério Batista Medeiros; Celso Francisco Hernandez Granato; Maria Lúcia Ferraz
Journal:  Braz J Infect Dis       Date:  2016-03-26       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.